Haleon HLN
NYSE HLN
$9.86 -0.01 (-0.05%)
As of: Aug 20, 2026 · 3:22 PM EDT

Haleon (HLN) Cash from Investing Activities Growth (3y) (2025)

Haleon (HLN) Cash from Investing Activities Growth (3y) (2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Growth (3y) (Qtr)
1 Haleon 43.83 Bn 42.86 Bn - -
2 Teva Pharmaceutical Industries 43.07 Bn 39.42 Bn 2.15 Bn -53.63%
3 Zoetis 31.45 Bn 29.77 Bn 1.05 Bn -55.36%
4 Takeda Pharmaceutical 28.60 Bn 22.80 Bn 5.10 Bn 34.35%
5 United Therapeutics 22.23 Bn 19.57 Bn 683.80 Mn 33.61%
6 Viatris 18.75 Bn 17.86 Bn 1.46 Bn 15.92%
7 Neurocrine Biosciences 15.47 Bn 15.08 Bn 935.80 Mn -2.45%
8 Elanco Animal Health 11.70 Bn 11.17 Bn 798.00 Mn -36.76%
9 Dr Reddys Laboratories 10.13 Bn 9.97 Bn - -
10 Alkermes 8.12 Bn 7.47 Bn 397.90 Mn -26.41%

Historic Data

Download Data
DateValue
Dec 31, 2025 78.38%